# Polar Power, Inc.: financial statements, quarterly

POLA · Nasdaq · CIK 1622345 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pola.md) · [Financials](/companies/pola/financials.md) · [Filings](/companies/pola/filings.md) · [Insiders](/companies/pola/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pola/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [1,911](/filings/0001493152-24-045866.md) | [3,605 d](/filings/0001641172-25-001504.md) | [1,775](/filings/0001641172-25-010887.md) | [4,660](/filings/0001641172-25-023986.md) | [4,914](/filings/0001493152-25-024286.md) | [2,622 d](/filings/0001493152-26-016671.md) | [1,723](/filings/0001493152-26-024680.md) | [2,708](/filings/0001493152-26-039040.md) | [1,273](/filings/0001493152-25-024286.md) | [600 d](/filings/0001493152-26-016671.md) | [1,728](/filings/0001493152-26-024680.md) | [1,019](/filings/0001493152-26-039040.md) |
| Cost of revenue | $k | [2,019](/filings/0001493152-24-045866.md) | [5,032 d](/filings/0001641172-25-001504.md) | [2,177](/filings/0001641172-25-010887.md) | [2,828](/filings/0001641172-25-023986.md) | [3,490](/filings/0001493152-25-024286.md) | [4,162 d](/filings/0001493152-26-016671.md) | [1,403](/filings/0001493152-26-024680.md) | [1,778](/filings/0001493152-26-039040.md) | [3,533](/filings/0001493152-25-024286.md) | [2,745 d](/filings/0001493152-26-016671.md) | [593](/filings/0001493152-26-024680.md) | [1,356](/filings/0001493152-26-039040.md) |
| Gross profit | $k | [(108)](/filings/0001493152-24-045866.md) | [(1,427) d](/filings/0001641172-25-001504.md) | [(402)](/filings/0001641172-25-010887.md) | [1,832](/filings/0001641172-25-023986.md) | [1,424](/filings/0001493152-25-024286.md) | [(1,540) d](/filings/0001493152-26-016671.md) | [320](/filings/0001493152-26-024680.md) | [930](/filings/0001493152-26-039040.md) | [(2,260)](/filings/0001493152-25-024286.md) | [(2,145) d](/filings/0001493152-26-016671.md) | [1,135](/filings/0001493152-26-024680.md) | [(337)](/filings/0001493152-26-039040.md) |
| Research and development | $k | [299](/filings/0001493152-24-045866.md) | [239 d](/filings/0001641172-25-001504.md) | [220](/filings/0001641172-25-010887.md) | [195](/filings/0001641172-25-023986.md) | [172](/filings/0001493152-25-024286.md) | [185 d](/filings/0001493152-26-016671.md) | [160](/filings/0001493152-26-024680.md) | [146](/filings/0001493152-26-039040.md) | [157](/filings/0001493152-25-024286.md) | [183 d](/filings/0001493152-26-016671.md) | [169](/filings/0001493152-26-024680.md) | [128](/filings/0001493152-26-039040.md) |
| Operating income | $k | [(1,673)](/filings/0001493152-24-045866.md) | [(2,972) d](/filings/0001641172-25-001504.md) | [(1,979)](/filings/0001641172-25-010887.md) | [460](/filings/0001641172-25-023986.md) | [40.0](/filings/0001493152-25-024286.md) | [(2,896) d](/filings/0001493152-26-016671.md) | [(1,101)](/filings/0001493152-26-024680.md) | [(110)](/filings/0001493152-26-039040.md) | [(3,877)](/filings/0001493152-25-024286.md) | [(3,334) d](/filings/0001493152-26-016671.md) | [24.0](/filings/0001493152-26-024680.md) | [(1,671)](/filings/0001493152-26-039040.md) |
| Interest expense | $k | [171](/filings/0001493152-23-041120.md) | [184 d](/filings/0001493152-24-012355.md) | [163](/filings/0001493152-24-019861.md) | [179](/filings/0001641172-25-023986.md) | [153](/filings/0001493152-25-024286.md) | [153 d](/filings/0001493152-26-016671.md) | [164](/filings/0001493152-26-024680.md) | [171](/filings/0001493152-26-039040.md) | [208](/filings/0001493152-25-024286.md) | [177 d](/filings/0001493152-26-016671.md) | [202](/filings/0001493152-26-024680.md) | [447](/filings/0001493152-26-039040.md) |
| Income tax | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $k | [(1,844)](/filings/0001493152-24-045866.md) | [(3,155) d](/filings/0001641172-25-001504.md) | [(2,142)](/filings/0001641172-25-010887.md) | [501](/filings/0001641172-25-023986.md) | [13.0](/filings/0001493152-25-024286.md) | [(3,049) d](/filings/0001493152-26-016671.md) | [(1,265)](/filings/0001493152-26-024680.md) | [(271)](/filings/0001493152-26-039040.md) | [(4,085)](/filings/0001493152-25-024286.md) | [(3,512) d](/filings/0001493152-26-016671.md) | [(178)](/filings/0001493152-26-024680.md) | [(1,831)](/filings/0001493152-26-039040.md) |
| Diluted EPS | $ per share | [(0.14)](/filings/0001493152-24-045866.md) | not reported | [(0.85)](/filings/0001641172-25-010887.md) | [0.20](/filings/0001641172-25-023986.md) | [0.01](/filings/0001493152-25-024286.md) | not reported | [(0.50)](/filings/0001493152-26-024680.md) | [(0.11)](/filings/0001493152-26-039040.md) | [(1.63)](/filings/0001493152-25-024286.md) | not reported | [(0.05)](/filings/0001493152-26-024680.md) | [(0.49)](/filings/0001493152-26-039040.md) |
| Basic EPS | $ per share | [(0.14)](/filings/0001493152-24-045866.md) | not reported | [(0.85)](/filings/0001641172-25-010887.md) | [0.20](/filings/0001641172-25-023986.md) | [0.01](/filings/0001493152-25-024286.md) | not reported | [(0.50)](/filings/0001493152-26-024680.md) | [(0.11)](/filings/0001493152-26-039040.md) | [(1.63)](/filings/0001493152-25-024286.md) | not reported | [(0.05)](/filings/0001493152-26-024680.md) | [(0.49)](/filings/0001493152-26-039040.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: not reported
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.3](/filings/0001493152-23-041120.md) | [0.5](/filings/0001641172-25-001504.md) | [0.2](/filings/0001493152-24-019861.md) | [1.1](/filings/0001493152-24-032217.md) | [0.5](/filings/0001493152-24-045866.md) | [0.5](/filings/0001493152-26-016671.md) | [0.1](/filings/0001641172-25-010887.md) | [0.2](/filings/0001641172-25-023986.md) | [0.0](/filings/0001493152-25-024286.md) | [0.2](/filings/0001493152-26-039040.md) | [0.0](/filings/0001493152-26-024680.md) | [0.2](/filings/0001493152-26-039040.md) |
| Current assets | $m | [24.8](/filings/0001493152-23-041120.md) | [22.0](/filings/0001641172-25-001504.md) | [20.9](/filings/0001493152-24-019861.md) | [19.6](/filings/0001493152-24-032217.md) | [18.6](/filings/0001493152-24-045866.md) | [15.6](/filings/0001493152-26-016671.md) | [15.0](/filings/0001641172-25-010887.md) | [15.2](/filings/0001641172-25-023986.md) | [11.8](/filings/0001493152-25-024286.md) | [10.0](/filings/0001493152-26-039040.md) | [11.2](/filings/0001493152-26-024680.md) | [10.0](/filings/0001493152-26-039040.md) |
| Total assets | $m | [28.4](/filings/0001493152-23-041120.md) | [25.3](/filings/0001641172-25-001504.md) | [23.9](/filings/0001493152-24-019861.md) | [22.2](/filings/0001493152-24-032217.md) | [20.9](/filings/0001493152-24-045866.md) | [17.5](/filings/0001493152-26-016671.md) | [16.6](/filings/0001641172-25-010887.md) | [16.5](/filings/0001641172-25-023986.md) | [12.3](/filings/0001493152-25-024286.md) | [10.4](/filings/0001493152-26-039040.md) | [11.4](/filings/0001493152-26-024680.md) | [10.2](/filings/0001493152-26-039040.md) |
| Current liabilities | $m | [11.4](/filings/0001493152-23-041120.md) | [10.2](/filings/0001641172-25-001504.md) | [11.3](/filings/0001493152-24-019861.md) | [9.4](/filings/0001493152-24-032217.md) | [8.5](/filings/0001493152-24-045866.md) | [8.6](/filings/0001493152-26-016671.md) | [9.1](/filings/0001641172-25-010887.md) | [9.5](/filings/0001641172-25-023986.md) | [9.4](/filings/0001493152-25-024286.md) | [10.3](/filings/0001493152-26-024680.md) | [9.1](/filings/0001493152-26-024680.md) | not reported |
| Total liabilities | $m | [13.6](/filings/0001493152-23-041120.md) | [12.1](/filings/0001641172-25-001504.md) | [12.8](/filings/0001493152-24-019861.md) | [10.6](/filings/0001493152-24-032217.md) | [9.4](/filings/0001493152-24-045866.md) | [9.0](/filings/0001493152-26-016671.md) | [9.3](/filings/0001641172-25-010887.md) | [9.6](/filings/0001641172-25-023986.md) | [9.4](/filings/0001493152-25-024286.md) | [10.3](/filings/0001493152-26-039040.md) | [9.1](/filings/0001493152-26-024680.md) | [9.3](/filings/0001493152-26-039040.md) |
| Long-term debt | $m | not reported | [0.1](/filings/0001493152-24-012355.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [14.8](/filings/0001493152-24-045866.md) | [13.2](/filings/0001493152-26-016671.md) | [11.0](/filings/0001641172-25-023986.md) | [11.5](/filings/0001493152-25-024286.md) | [11.6](/filings/0001493152-25-024286.md) | [8.5](/filings/0001493152-26-039040.md) | [7.3](/filings/0001493152-26-039040.md) | [7.0](/filings/0001493152-26-039040.md) | [2.9](/filings/0001493152-25-024286.md) | [0.1](/filings/0001493152-26-039040.md) | [2.4](/filings/0001493152-26-039040.md) | [0.9](/filings/0001493152-26-039040.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(280) d](/filings/0001493152-24-045866.md) | [(346) d](/filings/0001641172-25-001504.md) | [(989)](/filings/0001641172-25-010887.md) | [1,179 d](/filings/0001641172-25-023986.md) | [(590) d](/filings/0001493152-25-024286.md) | [(136) d](/filings/0001493152-26-016671.md) | [(584)](/filings/0001493152-26-024680.md) | [(404) d](/filings/0001493152-26-039040.md) | [399 d](/filings/0001493152-25-024286.md) | [(472) d](/filings/0001493152-26-016671.md) | [(2,191)](/filings/0001493152-26-024680.md) | [20.0 d](/filings/0001493152-26-039040.md) |
| Capital expenditure | $k | [0.0 d](/filings/0001493152-24-045866.md) | [0.0 d](/filings/0001641172-25-001504.md) | not reported | not reported | [0.0 d](/filings/0001493152-25-024286.md) | [1.0 d](/filings/0001493152-26-016671.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [12.8](/filings/0001493152-23-041120.md) | [12.9](/filings/0001493152-24-019861.md) | [12.9](/filings/0001493152-24-032217.md) | [12.9](/filings/0001493152-24-045866.md) | [2.5](/filings/0001641172-25-010887.md) | [2.5](/filings/0001641172-25-023986.md) | [2.5](/filings/0001493152-25-024286.md) | [2.5](/filings/0001493152-26-024680.md) | [2.5](/filings/0001493152-26-039040.md) | [2.5](/filings/0001493152-25-024286.md) | [3.5](/filings/0001493152-26-024680.md) | [3.7](/filings/0001493152-26-039040.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 3,851,684 at 2026-08-17, from the cover of the [10-Q filed 2026-08-18](/filings/0001493152-26-039040.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. No prices; not investment advice.